These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11424620)

  • 1. [Care recommendations for type 1 neurofibromatosis].
    Donadio A; Garavelli L; Lorenzetti ME; Villani AR; Banchini G; Virdis R
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):83-7. PubMed ID: 11424620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
    Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 clinical features and management.
    Scalzone M; Coccia P; Ruggiero A; Riccardi R
    Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
    Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
    J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.
    Wolkenstein P; Frèche B; Zeller J; Revuz J
    Arch Dermatol; 1996 Nov; 132(11):1333-6. PubMed ID: 8915311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
    Gutmann DH; Aylsworth A; Carey JC; Korf B; Marks J; Pyeritz RE; Rubenstein A; Viskochil D
    JAMA; 1997 Jul; 278(1):51-7. PubMed ID: 9207339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
    Ferner RE; Gutmann DH
    Cancer Res; 2002 Mar; 62(5):1573-7. PubMed ID: 11894862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1--an update and review for the primary pediatrician.
    Goldberg Y; Dibbern K; Klein J; Riccardi VM; Graham JM
    Clin Pediatr (Phila); 1996 Nov; 35(11):545-61. PubMed ID: 8953130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health supervision for children with neurofibromatosis.
    Hersh JH;
    Pediatrics; 2008 Mar; 121(3):633-42. PubMed ID: 18310216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous clinical management of patients with neurofibromatosis type 1].
    Ohno K
    Nihon Rinsho; 2010 Jan; 68(1):131-5. PubMed ID: 20077805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients.
    Parrozzani R; Clementi M; Frizziero L; Miglionico G; Perrini P; Cavarzeran F; Kotsafti O; Comacchio F; Trevisson E; Convento E; Fusetti S; Midena E
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6036-42. PubMed ID: 26393470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing neurofibromatosis type I in children.
    Davis RE
    Nurse Pract; 1997 Apr; 22(4):73-6, 79-81. PubMed ID: 9128879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.